Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety
Wolfgang Hiddemann, Anna Maria Barbui, Miguel A Canales, Paul K Cannell, Graham P Collins, Jan Duerig, Roswitha Forstpointner, Michael Herold, Mark Hertzberg, Magdalena Klanova, John Radford, John F Seymour, Kensei Tobinai, Judith Trotman, Alis Burciu, Gunter Fingerle-Rowson, Marcel Wolbers, Tina Nielsen, Robert E Marcus
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2018
GALLIUM was sponsored by F. Hoffmann-La Roche. G.P.C. was supported by the Blood Theme of the Oxford National Institute for Health Research Biomedical Research Centre. Third-party medical writing assistance was funded by F. Hoffmann-La Roche.